Table 3.
Influence of Serum CD4+CD25+ T Cells, NK Cells, and T Cells Subgroup in PFS (Apatinib Group).
| Immune Cells | Case | mPFS (Months) | 95% CI | P |
|---|---|---|---|---|
| CD4+CD25+ cells | ||||
| ≥12.06 | 21 | 4.2 | 2.104-6.296 | .620 |
| <12.06 | 21 | 5.2 | 2.778-7.622 | |
| CD4+CD25+CD127low/− | ||||
| ≥5.255 | 21 | 4.2 | 1.726-6.674 | .444 |
| <5.255 | 21 | 4.5 | 4.112-4.888 | |
| NK cells | ||||
| ≥16.75 | 21 | 4.6 | 3.855-5.345 | .673 |
| <16.75 | 21 | 3.3 | 0.681-5.345 | |
| T cells | ||||
| ≥74.45 | 21 | 4.5 | 1.972-7.028 | .519 |
| <74.45 | 21 | 4.4 | 2.120-6.680 | |
| Th cells | ||||
| ≥41.95 | 21 | 4.2 | 1.962-6.438 | .224 |
| <41.95 | 21 | 5.4 | 2.845-7.955 | |
| Ts cells | ||||
| ≥29.1 | 21 | 5.2 | 3.917-6.483 | .132 |
| <29.1 | 21 | 4.2 | 1.794-6.606 | |
| Th/Ts | ||||
| ≥1.495 | 21 | 4.2 | 1.794-6.606 | .197 |
| <1.495 | 21 | 5.2 | 3.913-6.487 |
Abbreviations: CI, confidence interval; mPFS, median progression-free survival; NK, natural killer.